Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Targeted Clinical Development | Geron Corporation | Evaluation of Safety and Preliminary Efficacy of Escalating Doses of GRNOPC1 in Subacute Spinal Cord Injury | $0 |
| Disease Team Therapy Planning I | Geron Corporation | Preclinical Development and First-In-Human Testing of GRNCM1 in Advanced Heart Failure | $0 |
Total: $0.00 |
